PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Oh You Pretty Things Limited are a chain of Champagne and cocktail bars specifically designed for regional department stores and shopping centres. They serve indulgent treats, champagne, cocktails and coffee in stunning bars across the UK such as Manchester, Gateshead, Leeds and Essex. They have also signed a concession agreement to roll out 11 bars within a major UK retailer and will be opening the first on Oxford Street in April 2017.
days to go:
Expired
investment:
£693,000
H2O-ganics is using brand new technology to transform UK crop-growing. They are able to use this technology to grow vegetables indoors, without the need for pesticides and protected from disease and environmental factors.
days to go:
Expired
investment:
£76,418
CityMunch allows restaurants to catch potential customers through real time offer platforms. Allowing restaurants to attract customers specifically in the least busiest times of the day. CityMunch will use the funding to expand throughout the city.
days to go:
Expired
investment:
£174,582
Stroodles are straws made from pasta, which eliminates the use of plastic and wet paper straws. It lasts over 1 hour, is tasteless, 100% biodegradable and edible. The company has received worldwide brand exposure through viral content via Unilad and BBC. It has B2B and B2C clients including Marriott and Ibis in Europe, and it has stockists in the UK and Austria. The company will use the funds to scale marketing and sales and to become the market leader in the straw market.
days to go:
Expired
investment:
£214,980
ManíLife is an all-natural Argentinian peanut butter without sugar and palm oil roasted by experts and blended in small batches to create an award-winning taste explosion. The company promotes peanut butter to new heights through the crafted method without the use of added ingredients. ManíLife aims to be the UK's no. 1 peanut butter and eventually the ultimate purveyor of peanut. Till date, the company has achieved 2.4x quarterly sales growth from December 2018 to December 2019. Listed in over 270 Waitrose stores, it is the only peanut butter in history to win 3 Great Taste Stars and over 1 million branded mini pots sold through recipe boxes in the last 2 years and 20,000 Instagram followers. ManíLife will use its proceeds for the support of 2 NPD launch, a major packaging change, and content creation trip back to the farm in Argentina.
days to go:
Expired
investment:
£296,580
Winebuyers connect vineyards and wine merchants directly to the end consumer revolutionising a traditional industry. They make their revenue by charging the suppliers a monthly fee and have had 2,700 companies registering their interest to be involved in the platform. The funding will go towards strengthening their infrastructure, extending their marketing activities and to growing the business quickly and efficiently.
(SEIS Partial)
days to go:
Expired
investment:
£568,870
